Britain's Plan to Lead in Healthcare Innovation and Patient Care

In 1928, a pivotal moment occurred within a laboratory at St Mary’s Hospital in Paddington. A British scientist's discovery would forever alter the course of medicine and healthcare.

Alexander Fleming's discovery of penicillin revolutionized the treatment of diseases. Infections and fatalities, previously considered incurable, became manageable, leading to the saving of countless lives in the following decades.

This groundbreaking discovery established Britain as a global leader in the life sciences. It is a position that requires continuous effort to maintain.

To foster innovation and attract investment in this crucial sector, decisive action is being taken. Simultaneously, efforts are underway to ensure the National Health Service (NHS) continues to access the best medicines and technologies.

The industrial strategy aims to re-establish the UK as a global leader in MedTech and medicines. This will provide a foundation for innovation within the NHS. By combining the expertise of the health service with the ingenuity of British scientists, cutting-edge treatments will be developed for patients, and the economy will be stimulated.

As part of a 10-year health plan, the NHS will expedite the adoption of promising innovations to enhance outcomes and maximize the value of existing technologies.

A commitment of £600 million, in partnership with the Wellcome Trust, has been made to establish a new health data research service. This service will provide researchers with secure and streamlined access to NHS data, reducing bureaucratic hurdles and accelerating the translation of NHS insights into tangible results, all while safeguarding patient data.